The Valley Desk

NCT02105987 · Interventional trial

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Overall registry status Completed

Phase 3

Conditions Infection, Human Immunodeficiency Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov